Full text: M Sathe et al. JPGN 2021; 72: 18-23. Evaluation of the Effectiveness of In-line Immobilized Lipase Cartridge in Enterally Fed Patients With Cystic Fibrosis
Background: Traditional pancreatic enzyme replacement therapy is not designed for use with enteral feedings. “Only 1 FDA-approved PERT (PERTZYE, Cheisi, Inc.) has a package insert with instructions on how to deliver the contents of the lowest dose capsule (4000 USP lipase unit) through gastrostomy tubes 14 French or larger…Two recently published studies demonstrated the safety, tolerability, and effect on FA absorption of a new enzyme strategy to aid fat digestion with continuous enteral feedings, a single use digestive cartridge containing immobilized lipase (RELiZORB; Alcresta Therapeutics, Newton, MA). The cartridge connects in-line with an enteral feeding set. As enteral formula flows through the cartridge, immobilized lipase enzyme hydrolyzes intact triglyceride fats within the formula into more absorbable forms, whereas the lipase is retained within the cartridge.”
- Weight percentiles reached 50% in 18%, 25.5%, and 28.9% of patients at 0, 6, and 12, respectively.
- BMI reached 50% in 37.1%, 49.1%, and 50.0% in patients at 0, 6, and 12 months, respectively.
My take: “Immobilized lipase cartridge use demonstrated statistically significant improvements in growth in patients with cystic fibrosis requiring enteral feedings.” Newer and more effective therapies for Cystic Fibrosis may decrease the need for enteral supplementation along with lipase cartridge.
Related blog posts:
- Cystic Fibrosis Expert Update 2017
- Nutrition Pearls: Fiber and Cystic Fibrosis
- Big Advance for Cystic Fibrosis -Who Will Benefit?
- Nutrition Guidelines for Cystic Fibrosis
- Complex Family of CFTR-Associated Disorders | gutsandgrowth
- N2U -Part 3: EoE, IBD, and Cystic Fibrosis | gutsandgrowth
- “Origins of Cystic Fibrosis Lung Disease” | gutsandgrowth
- Breaking down lung defenses in Cystic Fibrosis | gutsandgrowth
- Fluctuating Elastase Levels in Infants with Cystic Fibrosis …